Literature DB >> 29705894

Quality of Life in Patients with Non-melanoma Skin Cancer: Implications for Healthcare Education Services and Supports.

Robabeh Abedini1, Maryam Nasimi2, Pedram Noormohammad Pour1, Atie Moghtadaie3, Hamid Reza Tohidinik4.   

Abstract

Non-melanoma skin cancer (NMSC) is the most prevalent type of cancer among Caucasian populations worldwide. The purpose of this work was to measure quality of life (QOL) of the patients with diagnosis of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) who were referred to our cancer clinic. During 1 year, 95 patients were selected and asked to complete Dermatology Life Quality Index (DLQI) questionnaires. Ninety-five patients with NMSC (74 men and 21 women) with mean age of 64.6 ± 12.5 participated in this cross-sectional study. From 95 patients, 75 had BCC, 15 had SCC, and 5 patients had both SCC and BCC. The total DLQI scores of the all participants were between 0 and 16; the mean was 4.1 ± 4.25 and median was 2. Variables which were associated with impaired QOL were marital status (P = 0.03) and tumor location (P = 0.02). By using general dermatology QOL questionnaire, it had been demonstrated that patients with NMSC faced with minimal QOL impairment; also, this handicap was more pronounced in younger patients and singles and patients with tumors located in exposed areas. Our findings demonstrated a need to educate our patients to improve patients' knowledge about different aspects of disease.

Entities:  

Keywords:  DLQI; Quality of life; Skin cancer

Year:  2019        PMID: 29705894     DOI: 10.1007/s13187-018-1368-y

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  20 in total

1.  Trends in incidence of nonmelanoma skin cancers in Alberta, Canada, 1988-2007.

Authors:  G W Jung; A I Metelitsa; D C Dover; T G Salopek
Journal:  Br J Dermatol       Date:  2010-07       Impact factor: 9.302

Review 2.  Guidelines for the management of basal cell carcinoma.

Authors:  N R Telfer; G B Colver; C A Morton
Journal:  Br J Dermatol       Date:  2008-07       Impact factor: 9.302

3.  Creation of a quality of life instrument for nonmelanoma skin cancer patients.

Authors:  John S Rhee; B Alex Matthews; Marcy Neuburg; Mary Burzynski; Ann B Nattinger
Journal:  Laryngoscope       Date:  2005-07       Impact factor: 3.325

Review 4.  Nonmelanoma skin cancer.

Authors:  Randie H Kim; April W Armstrong
Journal:  Dermatol Clin       Date:  2011-10-21       Impact factor: 3.478

5.  Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer.

Authors:  John S Rhee; B Alex Matthews; Marcy Neuburg; Brent R Logan; Mary Burzynski; Ann B Nattinger
Journal:  Arch Facial Plast Surg       Date:  2006 Sep-Oct

Review 6.  Depression and cancer: an appraisal of the literature for prevalence, detection, and practice guideline development for psychological interventions.

Authors:  S M Sellick; D L Crooks
Journal:  Psychooncology       Date:  1999 Jul-Aug       Impact factor: 3.894

7.  Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma.

Authors:  Mary-Margaret Chren; Anju P Sahay; Daniel S Bertenthal; Saunak Sen; C Seth Landefeld
Journal:  J Invest Dermatol       Date:  2007-02-15       Impact factor: 8.551

8.  Skin cancer and quality of life: assessment with the Dermatology Life Quality Index.

Authors:  John S Rhee; B Alex Matthews; Marcy Neuburg; Timothy L Smith; Mary Burzynski; Ann B Nattinger
Journal:  Dermatol Surg       Date:  2004-04       Impact factor: 3.398

9.  Quality of life in health care of non-melanoma skin cancer - results of a pilot study.

Authors:  Julia Steinbauer; Michael Koller; Elisabeth Kohl; Sigrid Karrer; Michael Landthaler; Rolf-Markus Szeimies
Journal:  J Dtsch Dermatol Ges       Date:  2010-10-28       Impact factor: 5.584

10.  DLQI scores in vitiligo: reliability and validity of the Persian version.

Authors:  Shahin Aghaei; Manouchehr Sodaifi; Peyman Jafari; Nazila Mazharinia; Andrew Y Finlay
Journal:  BMC Dermatol       Date:  2004-08-04
View more
  9 in total

1.  Patient Perception of the Diagnosis Announcement and its Impact on Quality of Life of Patients with Primary Melanoma or Basal Cell Carcinoma.

Authors:  Marie Aymonier; Charles Taieb; Florence Corgibet; Pascal Joly; Jean-Francois Sei; Veronique Chaussade; Caroline Philippe; Khaled Ezzedine; Marie-Aleth Richard
Journal:  Acta Derm Venereol       Date:  2022-05-19       Impact factor: 3.875

2.  Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients.

Authors:  Sylke Schneider-Burrus; Athanasia Tsaousi; Sebastian Barbus; Johannes Huss-Marp; Katrin Witte; Kerstin Wolk; Björn Fritz; Robert Sabat
Journal:  Front Med (Lausanne)       Date:  2021-04-27

3.  Sex Differences in Health-related Quality of Life in Patients with Keratinocyte Carcinomas.

Authors:  Francesca Sampogna; Andrea Paradisi; Maria Luisa Iemboli; Luca Fania; Francesco Ricci; Monica Napolitano; Damiano Abeni
Journal:  Acta Derm Venereol       Date:  2021-04-27       Impact factor: 3.875

4.  Quality of Life in Patients with Surgically Removed Skin Tumors.

Authors:  Laura Răducu; Adelaida Avino; Raluca Purnichescu Purtan; Andra-Elena Balcangiu-Stroescu; Daniela Gabriela Bălan; Delia Timofte; Dorin Ionescu; Cristian-Radu Jecan
Journal:  Medicina (Kaunas)       Date:  2020-02-09       Impact factor: 2.430

5.  High-Dose-Rate Brachytherapy for the Treatment of Basal and Squamous Cell Carcinomas on Sensitive Areas of the Face: A Report of Clinical Outcomes and Acute and Subacute Toxicities.

Authors:  James M Taylor; Bahar Dasgeb; Spencer Liem; Ayesha Ali; Amy Harrison; Mitchell Finkelstein; Jisun Cha; Rani Anne; Steven Greenbaum; William Sherwin; Wenyin Shi
Journal:  Adv Radiat Oncol       Date:  2020-12-16

6.  Clinical Features and Prognosis of Young and Middle-Aged Adults With Skin Sebaceous Adenocarcinoma.

Authors:  Fan Wang; Xiu-Yun Wang; Xian Jiang
Journal:  Dermatol Surg       Date:  2022-06-21       Impact factor: 2.914

7.  Burden of Itch in Patients with Basal Cell Carcinoma.

Authors:  Iwona Chlebicka; Aleksandra A Stefaniak; Łukasz Matusiak; Jacek C Szepietowski
Journal:  Acta Derm Venereol       Date:  2021-07-30       Impact factor: 3.875

8.  Long-Term Efficacy of Vismodegib After its Withdrawal and Patients' Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI).

Authors:  Alessia Villani; Matteo Megna; Gabriella Fabbrocini; Milena Cappello; Maria Antonietta Luciano; Claudia Costa; Massimiliano Scalvenzi
Journal:  Dermatol Ther (Heidelb)       Date:  2019-09-10

Review 9.  Current Surgical Therapy of Locally Advanced cSCC: From Patient Selection to Microsurgical Tissue Transplant. Review.

Authors:  Tito Brambullo; Gian Paolo Azzena; Paolo Toninello; Giuseppe Masciopinto; Alberto De Lazzari; Bernardo Biffoli; Vincenzo Vindigni; Franco Bassetto
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.